In conclusion, our study is the first study to assess the plasma VEGF-B in NAFLD individuals and reveals that VEGF-B concentrations are independently associated with NAFLD. The gene discussed is VEGFB; the disease is metabolic dysfunction-associated steatotic liver disease.